<!-- received="Sun Dec 14 08:07:08 1997 MDT" -->
<!-- sent="14 Dec 1997 15:59:47 +0100" -->
<!-- name="Anders Sandberg" -->
<!-- email="asa@nada.kth.se" -->
<!-- subject="Re: Cryoprotectants anyone?" -->
<!-- id="3.0.16.19971214150724.2887adc6@pop.knoware.nl" -->
<!-- inreplyto="Sat, 13 Dec 1997 11:58:49 -0500 (EST)" -->
<title>extropians: Re: Cryoprotectants anyone?</title>
<h1>Re: Cryoprotectants anyone?</h1>
Anders Sandberg (<i>asa@nada.kth.se</i>)<br>
<i>14 Dec 1997 15:59:47 +0100</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#2447">[ date ]</a><a href="index.html#2447">[ thread ]</a><a href="subject.html#2447">[ subject ]</a><a href="author.html#2447">[ author ]</a>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="2448.html">John K Clark: "PHYS; Quantum Teleportation"</a>
<li> <b>Previous message:</b> <a href="2446.html">Eugene Leitl: "Re: DNA vaccines and pharmaceuticals-virus"</a>
<li> <b>In reply to:</b> <a href="2409.html">Twink: "Cryoprotectants anyone?"</a>
<!-- nextthread="start" -->
<li> <b>Next in thread:</b> <a href="2450.html">Michael M. Butler: "Re: And the winner is..."</a>
<li> <b>Reply:</b> <a href="2450.html">Michael M. Butler: "Re: And the winner is..."</a>
<!-- reply="end" -->
</ul>
<hr>
<!-- body="start" -->
Twink &lt;neptune@mars.superlink.net&gt; writes:<br>
<p>
<i>&gt; To this end, I typed in the following schema, in hopes that someone will</i><br>
<i>&gt; either tell me:</i><br>
<i>&gt; </i><br>
<i>&gt;         a) it's already being done,</i><br>
<i>&gt;         b) it won't work, or</i><br>
<i>&gt;         c) it's a brilliant idea and let's get started.</i><br>
<p>
I would say it is a bit of all three. There is research being done on<br>
finding good cryoprotectants, but it is more narrow than your<br>
approach. A wide search would be useful, but it would be expensive and<br>
we need good specifications. I suppose the cryo people can comment<br>
more extensively on this topic.<br>
<p>
<i>&gt;         Engineering cryoprotectants:</i><br>
<i>&gt; The basic idea is to 	come up with specificaions for the ideal cryoprotectant</i><br>
<i>&gt; in detail.  And I mean, ultimately, in technical detail.  This will probably</i><br>
<i>&gt; involve</i><br>
<i>&gt; finding some rigorous tests, such as how well it allows cells to not suffer</i><br>
<i>&gt; damage, though I would advise other tests as well.  Perhaps some sort of</i><br>
<i>&gt; microstructure could be used as a test bed.</i><br>
<p>
I think this is the hard part, since damage is not just quantitative,<br>
it is also qualitative. Is it good if the cell walls are whole but<br>
some proteins are denaturated? I would suggest that the effect on the<br>
brain is the most important, but even there it is not clear what<br>
structures are the most important (sacrifice axons for synapses, or<br>
vice versa?).<br>
<p>
<pre>
-- 
-----------------------------------------------------------------------
Anders Sandberg                                      Towards Ascension!
asa@nada.kth.se                            <a href="http://www.nada.kth.se/~asa/">http://www.nada.kth.se/~asa/</a>
GCS/M/S/O d++ -p+ c++++ !l u+ e++ m++ s+/+ n--- h+/* f+ g+ w++ t+ r+ !y
</pre>
<!-- body="end" -->
<hr>
<p>
<ul>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="2448.html">John K Clark: "PHYS; Quantum Teleportation"</a>
<li> <b>Previous message:</b> <a href="2446.html">Eugene Leitl: "Re: DNA vaccines and pharmaceuticals-virus"</a>
<li> <b>In reply to:</b> <a href="2409.html">Twink: "Cryoprotectants anyone?"</a>
<!-- nextthread="start" -->
<li> <b>Next in thread:</b> <a href="2450.html">Michael M. Butler: "Re: And the winner is..."</a>
<li> <b>Reply:</b> <a href="2450.html">Michael M. Butler: "Re: And the winner is..."</a>
<!-- reply="end" -->
</ul>
